Home

Richard I. Steinhart, CFO: BioXcel Therapeutics BTAIQ Sell · Filed 24/12/17

Trade details

Type
Insider sale
Amount
$73.8
Shares · price
205 sh · $0.36 a share
Held after
21,157 sh
Trade date
24/12/16
Filed
24/12/17
Days to filing
1 days

Sold 1.0% of holdings

Share of holding sold
1.0%

BioXcel Therapeutics trades, last 26 weeks

What else happened in BioXcel Therapeutics around then

Filed or reported within 30 days of the trade day · 24/11/16~25/01/15

Richard I. Steinhart's recent trades

  • Richard I. Steinhart

    Sell10b5-1 planBioXcel Therapeutics

    $7,461

    Filed 05/22

  • Richard I. Steinhart

    Planned sale10b5-1 planBioXcel Therapeutics

    $7,426

    Filed 05/20

  • Richard I. Steinhart

    Sell10b5-1 planBioXcel Therapeutics

    $134

    Filed 24/12/17

  • Richard I. Steinhart

    Sell10b5-1 planBioXcel Therapeutics

    $3,946

    Filed 24/10/03

  • Richard I. Steinhart

    Sell10b5-1 planBioXcel Therapeutics

    $246

    Filed 24/09/17

Richard I. Steinhart, CFO — sold $74 of BioXcel Therapeutics BTAIQ · 1.0% of holdings · 10b5-1 plan | Whalegun